λ‰΄μ˜¨ 둜고

λ‰΄μ˜¨ (123840) μ£Όκ°€ 및 μ’…λͺ© 정보

λ‰΄μ˜¨ μ£Όκ°€ 및 핡심 정보

ν˜„μž¬κ°€ 및 핡심 투자 정보
ν•­λͺ© κ°’
ν˜„μž¬κ°€ 1,685 원
λ³€λ™λŸ‰ 0 원
변동λ₯  0.00%
κΈ°μ€€ μ‹œκ°
거래 ꡬ뢄 μ‹œκ°„μ™Έ 거래
μ‹œμž₯ KOSDAQ
κ±°λž˜μ†Œ KRX
μ‹œκ°€ 1,690 원
κ³ κ°€ 1,695 원
μ €κ°€ 1,659 원
52μ£Ό λ²”μœ„ 1,355 원 ~ 14,011 원
κ±°λž˜λŸ‰ 4,333
κ±°λž˜λŒ€κΈˆ 7,282,266 원
μ‹œκ°€μ΄μ•‘ 262얡원
PER -0.92λ°°
PBR 0.64λ°°
EPS -11,338.6337 원
μ—…μ’… νœ΄λŒ€ν°λΆ€ν’ˆ

일별 μ£Όκ°€

κ³Όκ±° 일별 μ£Όκ°€ 정보
λ‚ μ§œ μ‹œκ°€ κ³ κ°€ μ €κ°€ μ’…κ°€ κ±°λž˜λŸ‰ κ±°λž˜λŒ€κΈˆ
2026.08.14 1,790 1,810 1,770 1,792 2,664 4,797,261
2026.08.18 1,935 1,935 1,741 1,795 6,950 12,590,923
2026.08.19 1,791 1,885 1,720 1,788 11,676 20,713,671
2026.08.20 1,771 1,823 1,744 1,779 4,146 7,427,407
2026.08.21 1,973 1,973 1,742 1,745 4,446 7,964,735
2026.08.24 1,731 1,820 1,731 1,731 4,484 7,912,124
2026.08.25 1,735 1,781 1,711 1,722 5,767 10,024,428
2026.08.26 1,729 1,749 1,700 1,700 1,623 2,804,434
2026.08.27 1,700 1,770 1,683 1,685 6,785 11,614,709
2026.08.28 1,690 1,695 1,659 1,685 4,333 7,282,266

νšŒμ‚¬ 정보

κΈ°μ—…μˆœμœ„ μ£Όμ‹μˆ˜ 외ꡭ인 비쀑 μ‚°μ—…κ΅° μ„ΈλΆ€ μ‚°μ—…κ΅°
KOSDAQ 1498μœ„ 15,553,050 0.40% ν•˜λ“œμ›¨μ–΄/ITμž₯λΉ„ νœ΄λŒ€ν°λΆ€ν’ˆ

κΈ°μ—… κ°œμš”

ν•œμΌμ§„κ³΅μ€ 2010λ…„ 3μ›” μ„€λ¦½λœ κΈ°μ—…μœΌλ‘œ 진곡 증착 μž₯λΉ„μ˜ 개발, 생산, νŒλ§€μ‚¬μ—…μ„ μ˜μœ„ν•˜κ³  μžˆλ‹€. μ£Όμš” 쒅속기업은 ν•œμΌμ‹ μž¬μƒ μ£Όμ‹νšŒμ‚¬κ°€ μžˆλ‹€. μ£Όμš” λ§€μΆœμ€ 진곡 증착 μž₯λΉ„ νŒλ§€μ—μ„œ λ°œμƒν•˜κ³  μžˆλ‹€. λ‹Ήμ‚¬λŠ” μ—¬λŸ¬ μ½”νŒ… 방식 쀑 Evaporation 방식을 μ±„νƒν•˜μ—¬ 특히 κ΄‘ν•™ 뢄야에 높은 기술λ ₯을 λ³΄μœ ν•˜κ³  있으며 슀마트폰의 보급 비쀑이 ν™•λŒ€λ˜λ©΄μ„œ 슀마트폰 λΆ€ν’ˆ μ—…μ²΄μ˜ μ½”νŒ… μž₯λΉ„ μˆ˜μš”κ°€ κΎΈμ€€ν•˜κ²Œ μ¦κ°€ν•˜κ³  μžˆλ‹€.

κ΄€λ ¨ ν…Œλ§ˆ

  • 슀마트폰 : νœ΄λŒ€ν° case 및 window μ½”νŒ…μš© 진곡 증착 μž₯λΉ„ 등을 μƒμ‚°ν•˜λŠ” 업체

AI예츑

AIμ˜ˆμΈ‘κΈ°λŠ” 이 μ’…λͺ©μ„ κ°•λ ₯맀도 Β· 맀도 Β· 쀑립 Β· 맀수 Β· κ°•λ ₯맀수 둜 μ˜ˆμΈ‘ν–ˆμ–΄μš”.

멀버십 ν”Œλžœμ„ κ΅¬λ…ν•˜λ©΄ μ˜ˆμƒ μ£Όκ°€ μ‹œλ‚˜λ¦¬μ˜€μ™€ AI의 투자의견, λͺ©ν‘œΒ·μ†μ ˆκ°€, AIκ°€ μ°Έκ³ ν•œ 차트 νŒ¨ν„΄λ“€μ„ 확인할 수 μžˆμŠ΅λ‹ˆλ‹€.

μ§€ν‘œλΆ„μ„

수읡λ₯  1μœ„ λ§€λ§€μ „λž΅μ€ 이 μ’…λͺ©μ„ 맀수 Β· 맀도 Β· 보유 Β· 관망 μ€‘μ΄μ—μš”.

멀버십 ν”Œλžœμ„ κ΅¬λ…ν•˜λ©΄ 수읡λ₯  1μœ„ λ§€λ§€μ „λž΅μ˜ 맀맀 μ‹œμ μ„ ν™•μΈν•˜κ³  λ‹€μŒ μ‹ ν˜Έλ₯Ό μ•Œλ¦ΌμœΌλ‘œ λ°›μ•„λ³Ό 수 μžˆμŠ΅λ‹ˆλ‹€.

μ΅œμ‹  κ΄€λ ¨ λ‰΄μŠ€

λ‰΄μ˜¨μ˜ 어린이 ν‚€ μ„±μž₯ 건강기λŠ₯μ‹ν’ˆ 'λ§€μ§ν‚€λ“œ'κ°€ μΆœμ‹œ 8κ°œμ›” λ§Œμ— λˆ„μ  맀좜 62얡원을 λ‹¬μ„±ν–ˆλ‹€. 7일 λ‰΄μ˜¨μ— λ”°λ₯΄λ©΄ λ§€μ§ν‚€λ“œλŠ” 2025λ…„ 12μ›”λΆ€ν„° μ§€λ‚œλ‹¬κΉŒμ§€ ν™ˆμ‡Όν•‘κ³Ό 온라인 채널을 ν•©μ‚°ν•΄ μ•½ 62μ–΅μ›μ˜ λˆ„μ  λ§€μΆœμ„ κΈ°λ‘ν–ˆλ‹€. μΆœμ‹œ 3μ£Ό λ§Œμ— 13만포 판맀λ₯Ό λ‹¬μ„±ν•œ 이후에도 재ꡬ맀 μˆ˜μš”κ°€ 이어지며 νŒλ§€λŸ‰μ΄ κΎΈμ€€νžˆ μ¦κ°€ν•˜κ³  μžˆλ‹€. λ§€μ§ν‚€λ“œλŠ” μ‹ν’ˆμ˜μ•½ν’ˆμ•ˆμ „μ²˜λ‘œλΆ€ν„° 어린이 ν‚€μ„±μž₯ κΈ°λŠ₯성을 인정받은 'ν•œμ‚Όλ©κ΅΄μΆ”μΆœλΆ„λ§(HSy2

라이프케어 λΈŒλžœλ“œ λ‰΄μ˜¨μ€ 어린이 ν‚€μ„±μž₯ 건강기λŠ₯μ‹ν’ˆ 'λ§€μ§ν‚€λ“œ'κ°€ μΆœμ‹œ 8κ°œμ›” λ§Œμ— λˆ„μ  맀좜 62얡원을 λ‹¬μ„±ν–ˆλ‹€κ³  7일 λ°ν˜”λ‹€. μ§ν‚€λ“œλŠ” 2025λ…„ 12μ›”λΆ€ν„° μ§€λ‚œλ‹¬κΉŒμ§€ ν™ˆμ‡Όν•‘κ³Ό 온라인 채널을 ν•©μ‚°ν•΄ μ•½ 62μ–΅μ›μ˜ λˆ„μ  λ§€μΆœμ„ κΈ°λ‘ν–ˆλ‹€. μΆœμ‹œ 3μ£Ό λ§Œμ— 13만 포 판맀λ₯Ό λ‹¬μ„±ν•œ 이후에도 재ꡬ맀 μˆ˜μš”κ°€ 이어지며 νŒλ§€λŸ‰μ΄ μ¦κ°€ν•˜κ³  μžˆλ‹€. λ§€μ§ν‚€λ“œλŠ” μ‹ν’ˆμ˜μ•½ν’ˆμ•ˆμ „μ²˜λ‘œλΆ€ν„° 어린이 ν‚€μ„±μž₯ κΈ°λŠ₯성을 인정받은 'ν•œμ‚Όλ©κ΅΄μΆ”μΆœλΆ„λ§(HSy2)'을 μ£Όμ›λ£Œλ‘œ μ μš©ν•˜κ³  뼈 ν˜•μ„±μ— 도움을 μ£ΌλŠ” 비타민K2을 λ”ν–ˆλ‹€. μ—λ„ˆμ§€ λŒ€μ‚¬μ— κ΄€μ—¬ν•˜λŠ” 비타민 B1, B2, B6, λ‚˜μ΄μ•„μ‹ κ³Ό 정상적인 λ©΄μ—­κΈ°λŠ₯에 ν•„μš”ν•œ 아연도 λ°°ν•©ν•΄ μ„±μž₯κ³Ό μ—λ„ˆμ§€, 면역을 λ™μ‹œμ— 관리할 수 μžˆλŠ” 10쀑 볡합 κΈ°λŠ₯μ„± ꡬ쑰λ₯Ό μ™„μ„±ν–ˆλ‹€....

κΈ€λ‘œλ²Œ 라이프케어 μ „λ¬ΈκΈ°μ—… λ‰΄μ˜¨μ΄ 체쀑 관리 건강기λŠ₯μ‹ν’ˆ 'μ‹œμ„œμŠ€ ν•„ λ‹€μ΄μ–΄νŠΈ'의 λˆ„μ  νŒλ§€λŸ‰μ΄ 7000λ§Œμ •μ„ λŒνŒŒν–ˆλ‹€κ³  31일 λ°ν˜”λ‹€. μ‹œμ„œμŠ€ ν•„ λ‹€μ΄μ–΄νŠΈλŠ” 2019λ…„ μΆœμ‹œ 이후 μ˜¬ν•΄ 6μ›”κΉŒμ§€ λˆ„μ  νŒλ§€λŸ‰ 7000λ§Œμ •μ„ κΈ°λ‘ν–ˆμœΌλ©°, κ°œλ³„μΈμ •ν˜• μ£Όμ›λ£ŒμΈ 'μ‹œμ„œμŠ€μΆ”μΆœλ¬Ό' κΈ°μ€€ λˆ„μ  λ§€μΆœμ•‘ μ—­μ‹œ 1053얡원을 λŒνŒŒν–ˆλ‹€. νšŒμ‚¬λŠ” 지속적인 고객 μˆ˜μš”λ₯Ό λ°”νƒ•μœΌλ‘œ μ•ˆμ •μ μΈ 판맀 흐름을 μœ μ§€ν•˜λ©° κ΅­λ‚΄ 체쀑 관리 μ‹œμž₯μ—μ„œμ˜ 독보적 μž…μ§€λ₯Ό λ‹€μ‹œ ν•œλ²ˆ ν™•μΈν–ˆλ‹€κ³  μ„€λͺ…ν–ˆλ‹€. 졜근 세계 λΉ„λ§Œ 치료제 μ‹œμž₯μ—μ„œ 글루카곀 μœ μ‚¬ νŽ©νƒ€μ΄λ“œ-1 기반 약물이 μ£Όλͺ©λ°›μŒμ— 따라, 식물 유래 GLP-1 기전을 κ°–μΆ˜ μ‹œμ„œμŠ€μΆ”μΆœλ¬Ό κ΄€λ ¨ 연ꡬ도 ν•¨κ»˜ μ£Όλͺ©λ°›κ³  μžˆλ‹€. GLP-1은 'μœ„κ³ λΉ„', '마운자둜' λ“± μ΅œμ‹  λΉ„λ§Œ 치료제의 핡심 μž‘μš© κΈ°μ „μœΌλ‘œ, 체쀑 κ°λŸ‰ 및 μ‹μš• 쑰절 μΈ‘λ©΄μ—μ„œ μ£Όμš” 생리적 μ§€ν‘œλ‘œ ν‰κ°€λ°›λŠ”λ‹€....

라이프케어 μ „λ¬ΈκΈ°μ—… λ‰΄μ˜¨μ΄ 체쀑 관리 건강기λŠ₯μ‹ν’ˆ 'μ‹œμ„œμŠ€ ν•„ λ‹€μ΄μ–΄νŠΈ'의 λˆ„μ  νŒλ§€λŸ‰ 7000λ§Œμ •μ„ λŒνŒŒν•˜λ©° 체쀑 관리 μ‹œ...

μ‹€μ ν˜„ν™©

λ§€μΆœμ•‘

κΈ°κ°„ ꡬ뢄 λ§€μΆœμ•‘ μ¦κ°€μœ¨
2025 μ—°κ°„ (YoY) 48,163,918,636 184.20%
2024 μ—°κ°„ (YoY) 16,947,296,982 251.53%
2023 μ—°κ°„ (YoY) 4,821,046,542 -30.21%
2022 μ—°κ°„ (YoY) 6,907,587,000 -31.51%
2026.2Q λΆ„κΈ° (QoQ) 13,831,121,000 1.38%
2026.1Q λΆ„κΈ° (QoQ) 13,642,499,613 71.11%
2025.4Q λΆ„κΈ° (QoQ) 7,972,984,078 -52.89%
2025.3Q λΆ„κΈ° (QoQ) 16,923,389,889 17.86%

μ˜μ—…μ΄μ΅

κΈ°κ°„ ꡬ뢄 μ˜μ—…μ΄μ΅ μ¦κ°€μœ¨
2025 μ—°κ°„ (YoY) -13,377,903,124 -14.50%
2024 μ—°κ°„ (YoY) -11,684,045,292 -11.47%
2023 μ—°κ°„ (YoY) -10,481,415,137 -31.75%
2022 μ—°κ°„ (YoY) -7,955,817,500 -7.25%
2026.2Q λΆ„κΈ° (QoQ) 182,354,733 108.79%
2026.1Q λΆ„κΈ° (QoQ) -2,074,479,221 -551.54%
2025.4Q λΆ„κΈ° (QoQ) -318,393,965 91.71%
2025.3Q λΆ„κΈ° (QoQ) -3,839,257,603 -10.97%

순이읡

κΈ°κ°„ ꡬ뢄 순이읡 μ¦κ°€μœ¨
2025 μ—°κ°„ (YoY) -38,807,779,737 -5.63%
2024 μ—°κ°„ (YoY) -36,737,800,894 -53.59%
2023 μ—°κ°„ (YoY) -23,918,960,603 60.62%
2022 μ—°κ°„ (YoY) -60,734,620,000 -46.22%
2026.2Q λΆ„κΈ° (QoQ) -13,116,840,336 -81.71%
2026.1Q λΆ„κΈ° (QoQ) -7,218,481,006 51.60%
2025.4Q λΆ„κΈ° (QoQ) -14,914,250,828 -8.58%
2025.3Q λΆ„κΈ° (QoQ) -13,735,893,885 -3399.06%

μˆœλ§€μˆ˜λŸ‰

개인: -396

κΈ°κ΄€: 0

외인: 396

λˆ„μ  μˆœλ§€μˆ˜λŸ‰

개인: -12,519

κΈ°κ΄€: 0

외인: 12,519

순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2026-08-28 -396 - 396
2026-08-27 -1,253 - 1,253
2026-08-26 43 - -43
2026-08-25 1,483 - -1,483
2026-08-24 382 - -382
2026-08-21 1,248 - -1,248
2026-08-20 -332 - 332
2026-08-19 -1,773 - 1,773
2026-08-18 215 - -215
2026-08-14 -679 - 679
2026-08-13 -1,473 - 1,473
2026-08-12 1,062 - -1,062
2026-08-11 -2,866 - 2,866
2026-08-10 3,224 - -3,224
2026-08-07 5,454 - -5,454
2026-08-06 936 - -936
2026-08-05 -494 - 494
2026-08-04 -393 - 393
2026-08-03 2,326 - -2,326
2026-07-31 -2,336 - 2,336
2026-07-30 -5,683 - 5,683

λˆ„μ  순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2026-08-28 -1,305 - 1,305
2026-08-27 -909 - 909
2026-08-26 344 - -344
2026-08-25 301 - -301
2026-08-24 -1,182 - 1,182
2026-08-21 -1,564 - 1,564
2026-08-20 -2,812 - 2,812
2026-08-19 -2,480 - 2,480
2026-08-18 -707 - 707
2026-08-14 -922 - 922
2026-08-13 -243 - 243
2026-08-12 1,230 - -1,230
2026-08-11 168 - -168
2026-08-10 3,034 - -3,034
2026-08-07 -190 - 190
2026-08-06 -5,644 - 5,644
2026-08-05 -6,580 - 6,580
2026-08-04 -6,086 - 6,086
2026-08-03 -5,693 - 5,693
2026-07-31 -8,019 - 8,019
2026-07-30 -5,683 - 5,683

μžμ‚° λΉ„μœ¨

μžμ‚°μ΄κ³„ λΆ€μ±„λΉ„μœ¨ μžλ³ΈλΉ„μœ¨
83,697,157,585 11.50% 88.50%

맀좜 ꡬ성

ꡬ성 μš”μ†Œ λΉ„μœ¨
기타 54.53%
νœ΄λŒ€ν° κ΄€λ ¨ [진곡증착μž₯λΉ„] 34.01%
μΌλ°˜κ΄‘ν•™ [진곡증착μž₯λΉ„] 11.46%

곡맀도 ν˜„ν™©

졜근 곡맀도 κ±°λž˜λŸ‰: 0 (0%)

졜근 곡맀도 μž”κ³ : 0 (0%)

곡맀도 κ±°λž˜λŸ‰

λ‚ μ§œ μ’…κ°€ κ³΅λ§€λ„λŸ‰ 곡맀도비쀑
2026-08-28 1,685 0 0.00%
2026-08-27 1,685 0 0.00%
2026-08-26 1,700 0 0.00%
2026-08-25 1,722 36 0.62%
2026-08-24 1,731 0 0.00%
2026-08-21 1,745 52 1.17%
2026-08-20 1,779 78 1.88%
2026-08-19 1,788 82 0.70%
2026-08-18 1,795 82 1.18%
2026-08-14 1,792 0 0.00%
2026-08-13 1,801 17 0.14%
2026-08-12 1,800 24 0.16%
2026-08-11 1,880 26 0.27%
2026-08-10 1,865 79 0.24%
2026-08-07 1,966 30 0.04%
2026-08-06 1,893 0 0.00%
2026-08-05 1,816 0 0.00%
2026-08-04 1,755 0 0.00%
2026-08-03 1,705 12 0.14%
2026-07-31 1,707 85 0.35%
2026-07-30 1,504 109 0.31%

곡맀도 μž”κ³ 

λ‚ μ§œ μ’…κ°€ 곡맀도 μž”κ³  곡맀도 비쀑
2026-08-26 1,700 0 0.00%
2026-08-25 1,722 0 0.00%
2026-08-24 1,731 0 0.00%
2026-08-21 1,745 0 0.00%
2026-08-20 1,779 0 0.00%
2026-08-19 1,788 0 0.00%
2026-08-18 1,795 0 0.00%
2026-08-14 1,792 0 0.00%
2026-08-13 1,801 0 0.00%
2026-08-12 1,800 0 0.00%
2026-08-11 1,880 0 0.00%
2026-08-10 1,865 0 0.00%
2026-08-07 1,966 0 0.00%
2026-08-06 1,893 0 0.00%
2026-08-05 1,816 0 0.00%
2026-08-04 1,755 0 0.00%
2026-08-03 1,705 0 0.00%
2026-07-31 1,707 0 0.00%
2026-07-30 1,504 0 0.00%
2026-07-29 1,823 0 0.00%
2026-07-28 1,963 0 0.00%

μ—…μ’… λ‚΄ 비ꡐ

νœ΄λŒ€ν°λΆ€ν’ˆ μ—…μ’…(55개) μ—°κ°„ κΈ°μ€€

ν•­λͺ© ν˜„μž¬ μ’…λͺ© μ—…μ’… 평균 μ—…μ’… λ‚΄ μˆœμœ„
μ‹œκ°€μ΄μ•‘ 262.069 1,270.01 48μœ„
PER(졜근4λΆ„κΈ°) -0.162 -244.64 34μœ„
PBR 0.102 0.93 54μœ„
ROE(졜근4λΆ„κΈ°) -40.028 -4 51μœ„
λ°°λ‹Ήμˆ˜μ΅λ₯ (μ΅œκ·Όμ—°λ„) - - -μœ„
μ˜μ—…μ΄μ΅λ₯ (μ΅œκ·Όμ—°λ„) -27.776 -10.42 50μœ„
순이읡λ₯ (μ΅œκ·Όμ—°λ„) -80.574 -7.13 52μœ„
λΆ€μ±„λΉ„μœ¨(μ΅œκ·Όμ—°λ„) 26.199 79.7 43μœ„
λ§€μΆœμ•‘(μ΅œκ·Όμ—°λ„) 481.639 2,790.26 41μœ„
μ˜μ—…μ΄μ΅(μ΅œκ·Όμ—°λ„) -133.779 43.02 50μœ„
λ‹ΉκΈ°μˆœμ΄μ΅(μ΅œκ·Όμ—°λ„) -388.078 30.9 54μœ„